• D K Menon and A Ercole.
• Division of Anaesthesia, University of Cambridge and Neurosciences/Trauma Critical Care Unit, Addenbrooke's Hospital, Cambridge, UK. Electronic address: dkm13@cam.ac.uk.
• Handb Clin Neurol. 2017 Jan 1; 140: 239-274.

AbstractTraumatic brain injury (TBI) is a growing global problem, which is responsible for a substantial burden of disability and death, and which generates substantial healthcare costs. High-quality intensive care can save lives and improve the quality of outcome. TBI is extremely heterogeneous in terms of clinical presentation, pathophysiology, and outcome. Current approaches to the critical care management of TBI are not underpinned by high-quality evidence, and many of the current therapies in use have not shown benefit in randomized control trials. However, observational studies have informed the development of authoritative international guidelines, and the use of multimodality monitoring may facilitate rational approaches to optimizing acute physiology, allowing clinicians to optimize the balance between benefit and risk from these interventions in individual patients. Such approaches, along with the emerging impact of advanced neuroimaging, genomics, and protein biomarkers, could lead to the development of precision medicine approaches to the intensive care management of TBI.© 2017 Elsevier B.V. All rights reserved.

10 keywords...

hide…